Omnicell Names Baird Radford as New CFO to Align Financial Strategy with Innovation Roadmap.
ByAinvest
Tuesday, Aug 26, 2025 5:13 am ET1min read
OMCL--
Radford's extensive background includes roles as Chief Financial Officer at Allakos Inc., Senior Vice President of Finance at Aimmune Therapeutics, and CFO at HeartFlow, an AI health-tech company. Prior to these positions, he held leadership roles at Intuitive Surgical, eBay, and PricewaterhouseCoopers [2].
The appointment of Radford comes as Omnicell continues its transformation into a digitally-enabled medication management technology company. The company aims to align its financial strategy with its innovation roadmap, positioning it to advance the industry-defined vision of the Autonomous Pharmacy. Randall Lipps, chairman, president, CEO, and founder of Omnicell, expressed his confidence in Radford's expertise to drive the company's strategy forward [1].
Omnicell, established in 1992, provides pharmacy and nursing care solutions through robotics, smart devices, and intelligent software workflows. The company's mission is to help healthcare facilities improve efficiency, reduce costs, and enhance supply chain control. The appointment of Radford is part of Omnicell's ongoing strategic initiatives to advance the Autonomous Pharmacy vision within the healthcare industry [2].
References:
[1] https://www.businesswire.com/news/home/20250825147622/en/Omnicell-Appoints-Baird-Radford-as-Executive-Vice-President-and-Chief-Financial-Officer
[2] https://www.investing.com/news/company-news/omnicell-appoints-baird-radford-as-new-cfo-effective-august-26-93CH-4209670
Omnicell has appointed Baird Radford as its new CFO, effective August 26, 2025. Radford has over 30 years of experience in healthcare and technology finance. The company aims to align its financial strategy with its innovation roadmap, enhancing its position as a digitally-enabled medication management technology company.
Omnicell, Inc. (Nasdaq: OMCL) has announced the appointment of Baird Radford as its new Executive Vice President and Chief Financial Officer, effective August 26, 2025. Radford, who brings over three decades of experience in healthcare and technology finance, will succeed Nchacha Etta, who will remain with the company in an advisory capacity through November 2025 to ensure a smooth transition [1].Radford's extensive background includes roles as Chief Financial Officer at Allakos Inc., Senior Vice President of Finance at Aimmune Therapeutics, and CFO at HeartFlow, an AI health-tech company. Prior to these positions, he held leadership roles at Intuitive Surgical, eBay, and PricewaterhouseCoopers [2].
The appointment of Radford comes as Omnicell continues its transformation into a digitally-enabled medication management technology company. The company aims to align its financial strategy with its innovation roadmap, positioning it to advance the industry-defined vision of the Autonomous Pharmacy. Randall Lipps, chairman, president, CEO, and founder of Omnicell, expressed his confidence in Radford's expertise to drive the company's strategy forward [1].
Omnicell, established in 1992, provides pharmacy and nursing care solutions through robotics, smart devices, and intelligent software workflows. The company's mission is to help healthcare facilities improve efficiency, reduce costs, and enhance supply chain control. The appointment of Radford is part of Omnicell's ongoing strategic initiatives to advance the Autonomous Pharmacy vision within the healthcare industry [2].
References:
[1] https://www.businesswire.com/news/home/20250825147622/en/Omnicell-Appoints-Baird-Radford-as-Executive-Vice-President-and-Chief-Financial-Officer
[2] https://www.investing.com/news/company-news/omnicell-appoints-baird-radford-as-new-cfo-effective-august-26-93CH-4209670

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet